Back to Search
MARK KEATING, M.D.
M.D.
Internal Medicine Physician
NPI: 1457309627Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
209012(MA)
Research & Publications (20)
Genetic approaches to disease and regeneration.
PMID 15293807·Philos Trans R Soc Lond B Biol Sci·2004
6-review
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
PMID 19646755·Leuk Res·2010
3-trial
Healthcare-associated hepatitis C virus transmission among patients in an abdominal organ transplant center.
PMID 19497073·Transpl Infect Dis·2009
8-other
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
PMID 19491390·Blood·2009
7-preclinical
The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course.
PMID 19131547·Blood·2009
8-other
Targeting DNA repair in chronic lymphocytic leukemia cells with a novel acyclic nucleotide analogue, GS-9219.
PMID 19435836·Clin Cancer Res·2009
8-other
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience.
PMID 19414856·Blood·2009
4-observational
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cells.
PMID 19182209·Blood·2009
8-other
Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes.
PMID 19369625·Am J Clin Pathol·2009
8-other
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
PMID 19318683·Blood·2009
8-other
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.
PMID 19242062·Cancer Biomark·2009
2-rct
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
PMID 19224852·J Clin Oncol·2009
8-other
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.
PMID 19234140·Blood·2009
8-other
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.
PMID 19458051·Clin Cancer Res·2009
8-other
Input subsidies to improve smallholder maize productivity in Malawi: toward an african green revolution.
PMID 19175292·PLoS Biol·2009
8-other
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
PMID 19637351·Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 250 MASS AVENUE, NOVARITIS
CAMBRIDGE, MA 02139 - Phone
- (617) 871-4059
Quick Facts
- NPI
- 1457309627
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile